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Results: 1) Right after coronary ligatlon, MR was only trace with limited 
increase in LV end-systolic volume (26 ~ 7 vs, f£ , 5 ml, p - 0.01), 2) 
After 8 weeks, moderato MR developed ~18 the LV dilated (44 ;t: 8 ml, p 
• 0,01 vs, acute), wllllout change in EF (36 ± 7% to 39 :! 3%), 3) As 
MR developed, the PM8 ~hlftod posteriorly nnd medlolatorNly, e~peclally the 
iechomlo medial PM (p - 0.0001). nnd the ennulue d(Inted (p < 0.01), The 
only Ind0pnndent predictor of MR was the Increase In the tethering dlsfnncs 
from PMs to enter(or onnulus (F = 0,86), 
Cenchmlen: LV r~nd PM Ischomln without dlk'ltntton lolls to produce im- 
port~nl MR, 18chemic MR with LV remodotleg relates strongly 1o chnngce In 
the 3D geometry of the PM nnd onnulnr mltrnl wive nttaehmenl~, 
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U~A 
Functional mltral mgutgifaflen (MR) IS caused by (~hnngoa in several oloment~ 
el the mifral vedva npp~r,llul~, IntorffCflen ,'~mong tl'l~so have fe cemplv wlfh 
fhe~ chordal !0roe dlstribulion defined by Ihe cllerdl~l ¢offplieg fomo~ (Fc) 
cro=1tod by II~o fr~n~mllml pressure difference |LVP,LAP), which close II~o 
le~fleft~ 0nd the chordal tell~orlng tomes (Fr) pulling 111o leaflets apart 
Fiv~ polc, lne mllr~ll valve:~ were invo.,'ltigfftod in t,~flo to lost |he Ilypofhe- 
sis that !uncflool~l MR la directly minted to t'dler('itlon~ el th~ chordal felts 
b~ll~nce, }:[Fc-Ft ) Independent vannlion,'~ of the spatiN poslt~ona of tl~o 
papdlnW mt.~elos nnd LVP-LAP ~llowed dtroct monsuromenl~ el F] and Fc 
with chordRP forte fran~dueem attaclled In tile primary chordao Chmdno 
geometry, mgurgtf~nt orifice area lEnA) ~nd oeclu~innal leaflet area (OLA) 
needed to covet the leaflet ortfico for a given I01~II01 eonliguration wore as. 
t~e~ged by 2D echo ~nd reconstructed thme.dimension~lly. OLA wa~ used aa 
expression tot Incomplete leaflet coffptofien, Regurgttant fraction (RF) was 
measured with an electromagnetic Ilowmolor, 
U,~lng ANOVA linear correlations wore teated between ~[Fc-F~ ]and OLA 
(regression cocfficmnt (mln-ma,q it = t15 65 ram:iN; p .  0.001), EOA 
(t~= .45 ..... 11mm;'/N,p. 0001)nndRF(t l~ 0,06 ,001 10 :'/N;p 
• 0,00t ), Incmn~mg Fr by papillary =lrtmcfu =nnldfignn~lof'd restricted leaflet 
mobility msult~ng ~n an apical and pestonor shill el the conptat~on line Anlenor 
fe~flef eoapf~ng forces Increased duo to m{fral leaflet remodeling generating 
n nonunlfom~ EOA, 
Altered chordal force distribullen caused functional MR based on tented 
leaflet conllguraflon obsowoo clinically. The data suggest that chordal rocon- 
sinK;finn sl)ould be considered to repair ischomic MR. 
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Introduction: Hospital modality in previous FDA studios of eardiomyoplasty 
has been t2-3t% Lower hospital mortality is likely to be required for ac- 
ceptable nsk,-'benolit. In order to mimmize oxpenenco as a factor in hospital 
mortality, the Cardiomyoplasty - Skeletal Muscle Assist Randomized Trial 
(C-SMART) instifuled a formal training plogram for all new surgeons. 
Methods: Surgical training included hands-on animal experience, obser- 
vation of e clinical case. and an expenenced surgeon at the first case. 
Between September 1994 and July 1997, 33 treatment patients received 
surgery 
Results: There was 1 early (within 30 days) witnessed suddo¢~ death after 
discharge from initial hospitalization. Median (range) length of surgery and 
hospilalization were: 
let case (52°0) others (48%) o.value 
skin-to-skin time (hrs) 56 (2 5-11 4) 6.1 (4.0 -9.2,', 0428 
ICU days .'L5 (2-r 1) 5 (2-7) 0904 
days hospLtahzed ~5 (7-;'9) 11,5 (6-20) 0.027 
Conclus)on.. Despite over 50% ef surgeries being the surgeon's initial 
cardiomyoplnety experience, early mortality has remained low (3%), end 
opemttvo time nnd dumtton of ICU slay wore not offoctod by surgeon expe- 
rience, This supports C-SMART'~ organized surgical training s,~ an effective 
tool to Improve early outcomes alter cnrdlomyoplasly, 
• Bridge to Recovery: Improved Survival In Patients 
With Acute Viral Myocerdltls Using Temporary 
External Pulaatllo Vontrlculer Support 
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AoufO vital myoe~rditi8 (AVM) c~n cause ri!pid o~rdi~e dQ(~omt~nst~t!0n lead, 
mg to n spectrum of clintcell outcomes, from lul! mcovon/to complete heart 
fftilur0, Conventional therapy with steroids, a0Omss!vo diuresis, and inotrop=c 
~upporl olfom the possibility o! complete myocardial ~vory ,  bet is ellen 
metlectivo with sqbseqtlont poet Ouleame5, We el(stained the AB!OMED vol, 
unte~ry world registry wifh the use of ~ temporary external pu!s,'lt~lo ventncular 
a~slst device, the BVS 5000 (EIVS), (n the setting o! AVM. 
16 patients with AVM underwent devic~ ~mptantation t I (69%) unde~,~ent 
bwentflcul~r support, 4 (~5'%) undorwenl Iofi ventncu!ar Support and 116%) 
undonNonf light ventrlculat SupPed for an average 01 9 days (range 1-62) 
The average age for this g!oup was 24 t 11 years Complete hemo~,nam=c 
data were ava0able for 9 AVM patients and are tabulated below 
Va.able PRE- I]VS ON I~VS OFF BVS 
Milan nP (nmd-(9) 6L'1 : 13 H0 t 12 74 ~ 14 
LellAtnum(mmHg) 24 I 4 12 t 5 15 ~ 3 
CVP(mmH0| 21 t t] 13 t ~ 14 : 4 
C I (IMmla}n',;)| t 4 ~ O 2 2 ~ ~ O G 36 ~ 0 7 
IBUN Iml'l/dl) 52 t 4.3 :]6 t 91 20 : 11 
Ctoabmno (mg!dl) 2 ~ , ! 5 I 7 = O ~ t 1 t O $ 
SGOT (lUll) 506 , ,%77 1C0 s 398 72 ~ 131 
Overall m this cohort, 5~ 156%) patients had inf¢,¢tlous complications. 2~ 
12~%) had ombohc events, and 5~1 (56%) expenencod penoperatwo "anal 
msulhmoncy. However, noarty half 01 these complK:attons dot, eloped peer to 
BVS assistance 9116 (56%) AVM patients wore both successtulty weaned 
tram device support and discharged homo. 
AVM represents one el the growing indications for which temporary me- 
chanical vontncular assistance may be most eltoctive Failure to achieve full 
vonlncular ecovery while on device support st=it allows for other surg~caf al- 
Iomatlvos, including implantation o! a long ten~ =mplantabfo ventncular assist 
device, or cardmc transplantabon 
[•  Improved Survival Rates Support Left Ventricular 
Assist Device Implantation Early After Myocardial 
Infarct ion 
J,M, Chen, J J  DeRose, J P Staler, TB Spamer, A,F Choudhn, 
T,M, Dewey, KA  Celanese, M.A Flannery, B.C. Sun, MC Oz Columbia 
Un)versd~: E)iv of Cardiothoracrc Surgeq/. NY. NY. 10032. USA 
Implantation of loll ventneular assist dowces (LVADs) early alter acute my- 
ocardial inlarction (Mr) has traditionally been thought to 13o <t~;sac,ated with 
high mortahty rates. A recovery ponod of hvo to three weeks is thus often 
mlposod pnor to LVAD implantation, thereby allowing for hemodynam=c and 
end-organ stabdization 
We invosbgated the impact of preoperatwo MI on the sur~,~val rates of 
patients who meowed a Thermo Cardiosystems fncoqooratc'~l (Tel) LVAD 
eLther. 2 weeks (EARLY) or -2 weeks (LATE) alter MI 
EARLY" LATE" 
Total Number 11 9 
Age (years) 5? 7 ~ 7 8 54 7 ~ 6 9 
Womef~ Men 1 10 2/7 
Pnoumatic'Electnc 47 5,4 
"time hem MI (Days) 6.8 : 51 22 9 : G4 
)ntraaort}c Balloon Pump 8 (72 7%) 6 (66 6°°) 
Pulmonary Capillary Wedge (mmHg) 28 0 i 5 3 28 6 : 8 8 
Cardiac Index (L/minim 2) 2 1 ~ 0 5 I 8 : 0 4 
Concomitant Right Ventncular Assist Device 1 (9.1%) 1 111 1~ o) 
Nitric Oxide 2 (18 2%) 0 
Percent Trallspianted 6 (54 6%) 5 (55.6°ol 
Percent Explanted : ~g.1%) 0 
Modishly 2 (18.2°,o) 4 (44.4%) 
'p - 0 05 EARLY vs LATE for all variables analyzed 
In the EARLY group, one patient died of multi-system organ failure 4 days 
after TCI LVAD insert)on, and another died of a pulmonary embolus 3 days 
after TCI LVAD insertion. One additional pat,ent in the EARLY group, who 
